The latest myeloma news
Investigators presented results of a phase II trial of a combination of three oral drugs…
Promising pre-clinical results using a bispecific T-cell engager (BiTE), an experimental immunotherapy agent to attack…
Multiple myeloma is a type of blood cancer in which malignant plasma cells, a type…
This content is password-protected. To view it, please enter the password below. Password:
More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues…
Multiple myeloma is the second most common haematological cancer, and despite significant progress in the…
A study of samples from patients with multiple myeloma (MM) has demonstrated how “reprogrammed” fat…
“Living with the uncertainty of whether cancer will develop is very difficult, so it’s exciting…
Interim results from a large international phase III clinical trial show that adding the immunotherapy…
Improving outcomes for patients with myeloid cancers who undergo stem cell transplantation was the focus…